| P2093 | author name string | Mabel Rodriguez | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | Cancer statistics, 2013 | Q27860762 |
| | Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors. | Q33627763 |
| | Aflibercept in the treatment of metastatic colorectal cancer | Q34635176 |
| | Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen | Q34642136 |
| | The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC) | Q35938926 |
| | A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer | Q37028989 |
| | A preclinical and clinical review of aflibercept for the management of cancer | Q37977598 |
| | Antiangiogenic drugs for colorectal cancer: exploring new possibilities | Q38024002 |
| | Targeted therapy for metastatic colorectal cancer: role of aflibercept | Q38055943 |
| | Nutritive value of human milk and nutritional status of wives of army personnel of low income from Rawalpindi | Q42117784 |
| | Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial. | Q53124033 |
| | Colorectal cancer | Q55924124 |
| P433 | issue | 5 | |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| | colorectal cancer | Q188874 |
| | aflibercept | Q4689286 |
| P304 | page(s) | 348-352 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | Journal of the advanced practitioner in oncology | Q26841994 |
| P1476 | title | Ziv-aflibercept use in metastatic colorectal cancer | |
| P478 | volume | 4 | |